Article Information
History
- January 20, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Anne Marie Holbrook, MD, PharmD, MSc, FRCPC1,2,*,
- Avrilynn Ding, MD3,
- Sue Troyan2,
- Sandra Costa2,
- Mark Matsos4,
- Michael R. Law5,
- Selena Gong6,
- Apurva Dixit7,
- Gary Foster8 and
- Nader Khalidi4
- 1Division of Clinical Pharmacology and Toxicology, Department of Medicine, McMaster University, Hamilton, Canada
- 2Clinical Pharmacology & Toxicology Research, Research Institute of St Joes Hamilton, St Joseph’s Healthcare Hamilton, Hamilton, Canada
- 3Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada
- 4Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Canada
- 5Centre for Health Services and Policy Research, School of Population and Public Health, UBC, Vancouver, Canada
- 6Institute of Medical Science, University of Toronto, Toronto, Canada
- 7Faculty of Medicine, University of Toronto, Toronto, Canada
- 8Biostatistics Unit, Research Institute of St Joes Hamilton, St Joseph’s Healthcare Hamilton, Hamilton, Canada
- ↵*Corresponding Author Dr Anne M Holbrook, MD,PharmD,MSc,FRCPC, Director, Division of Clinical Pharmacology & Toxicology, SJHH G623, 50 Charlton Ave East, Hamilton, ON L8N 4A6, holbrook{at}mcmaster.ca
Posted January 20, 2023.
Biologic DMARD Access and Medication Cost-related Nonadherence in Rheumatology Patients in Canada: A Cross-sectional Survey
